Liu Y, Zeng L, Zhang S, Zeng S, Huang J, Tang Y, et al. Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods. Med Oncol. 2013;30:528 pubmed publisher

Booth L, Roberts J, Sander C, Lee J, Kirkwood J, Poklepovic A, et al. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Oncotarget. 2017;8:16367-16386 pubmed publisher

Booth L, Roberts J, Poklepovic A, Dent P. PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]. Oncotarget. 2017;8:13464-13475 pubmed publisher

Booth L, Roberts J, Poklepovic A, Gordon S, Dent P. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide. Oncotarget. 2017;8:1449-1468 pubmed publisher

Tavallai M, Booth L, Roberts J, Poklepovic A, Dent P. Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor Therapeutic. Front Oncol. 2016;6:142 pubmed publisher

Booth L, Albers T, Roberts J, Tavallai M, Poklepovic A, Lebedyeva I, et al. Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo. Oncotarget. 2016;7:40398-40417 pubmed publisher

Booth L, Shuch B, Albers T, Roberts J, Tavallai M, Proniuk S, et al. Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function. Oncotarget. 2016;7:12975-96 pubmed publisher

Filone C, Caballero I, Dower K, Mendillo M, Cowley G, Santagata S, et al. The master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infection. PLoS Pathog. 2014;10:e1003904 pubmed publisher

Fujita M, Nakano K, Funato A, Sugita Y, Kubo T, Maeda H, et al. Heat shock protein27 expression and cell differentiation in ameloblastomas. Int J Med Sci. 2013;10:1271-7 pubmed publisher